Price Prediction
Anthropic (ANTHROPIC) Pre-IPO Price Prediction: Oversold tape meets heavy selling after the amended S-1 reset
Anthropic Pre-IPO Tokenized Index (ANTHROPIC) is trading at $1,372.40, down 3.31% on the day, while momentum remains stretched to the downside with a 14-day RSI of 23.44 and price sitting near the ...
The filing changed the story, but not the tape
ANTHROPIC is trading with a clear disconnect between operating momentum and market structure. On the company side, CNBC said Anthropic’s amended S-1 reported $16.96 billion of third-quarter revenue and $33.24 billion for the first nine months of 2026, while Reuters highlighted that revenue growth slowed in the third quarter and that the filing disclosed nearly $900 billion of compute commitments with partners including Amazon and Alphabet’s Google. That matters because the market is no longer looking only at growth; it is also pricing the scale of future infrastructure obligations tied to that growth.
On Binance Futures, the instrument itself is under pressure. The index is down 3.31% over 24 hours, trading at $1,372.40 after a $1,433.20 to $1,350.00 range, with $52.3 million in 24-hour volume. That is not a quiet drift lower; it is a market testing support while order flow leans defensive.
Technical structure: oversold, but still trending below trend
The chart is already damaged. Price is below the 7-day SMA at $1,459.55, the 12-day EMA at $1,539.09, the 20-day SMA at $1,694.85, and the 50-day SMA at $1,880.62. The wider structure still favors sellers until price can recover at least the pivot at $1,385.20 and then the immediate resistance at $1,420.40.
Momentum is washed out, but washed out does not mean reversal. The 14-day RSI at 23.44 is in oversold territory, Stochastic %K at 10.75 and %D at 8.60 show a deeply depressed short-term reading, and the %B position of 0.1006 leaves price close to the lower Bollinger Band at $1,291.34. That usually means downside is extended, not that downside is finished. The MACD remains negative at -147.9565, confirming the broader bearish impulse.
Volatility is elevated enough to matter. The 14-day ATR at $107.95 means intraday swings can be large relative to the current spot price, so any attempt to fade the decline has to respect the size of the move already in progress.
Positioning on Binance is long-biased, but flow is not confirming it
Derivatives positioning is leaning long across both Binance cohorts, but the tape is not rewarding that stance yet. Global Binance accounts are 82.0% long versus 18.0% short, while top-trader accounts are 84.4% long versus 15.6% short. Funding is neutral at 0.0050% for the 8-hour settlement, so the market is not showing an extreme one-way carry cost.
The more important intraday read is the taker flow. The taker buy/sell ratio is 0.6302, with buy volume of 281 versus sell volume of 446. That tells you aggressive sellers are still hitting the bid, even while most accounts remain net long. In other words, the market is crowded on the long side relative to the immediate execution flow.
Key levels traders will watch
Immediate support is $1,337.20, with stronger support at $1,302.00. Those levels matter because the current price is only modestly above them, and a break there would leave the lower Bollinger Band area as the next technical reference. On the upside, $1,385.20 is the pivot, $1,420.40 is the first resistance, and $1,468.40 is the stronger barrier. A move back through those levels would be the first sign that the post-filing selloff is stabilizing rather than extending.
What would change the setup
The bullish case is not a full trend reversal; it is a relief move off oversold conditions. For that to develop, ANTHROPIC needs to reclaim the pivot and hold above $1,385.20, then push through $1,420.40 while taker sell pressure eases.
The bearish case is straightforward: if support at $1,337.20 gives way, the market is likely to test $1,302.00 and potentially probe the lower Bollinger Band zone. Until price recovers above the near-term resistance band, the burden of proof stays with buyers.
The company catalyst is already on the table: the amended S-1 and its implications for growth, spending, and financing. No dated next catalyst was provided beyond that filing, so the timing of the next major driver is unclear.